Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Benson

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Investigational New Drugs|January 1, 1995
A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center StudyW J Gradishar, N J Vogelzang, L J Kilton, et al.
American Journal of Clinical Oncology|February 7, 2007
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinomaRobert de W Marsh, C M Rocha Lima, D E Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patientsA B Benson, O I Olopade, M J Ratain, et al.
The New England Journal of Medicine|April 20, 2001
Molecular predictors of survival after adjuvant chemotherapy for colon cancerT Watanabe, T T Wu, P J Catalano, et al.
Cancer|April 7, 1998
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literatureC Tellez, A B Benson, M T Lyster, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusB D Minsky, D Neuberg, D P Kelsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agentE Gupta, O I Olopade, M J Ratain, et al.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation|March 4, 2006
A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinomaP M Parikh, J Fuloria, G Babu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinomaA B Benson, E Mitchell, N Abramson, et al.
Cancer|November 7, 1998
High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology GroupS M Keller, L M Ryan, L R Coia, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|January 1, 1995
A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center StudyW J Gradishar, N J Vogelzang, L J Kilton, et al.
American Journal of Clinical Oncology|February 7, 2007
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinomaRobert de W Marsh, C M Rocha Lima, D E Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patientsA B Benson, O I Olopade, M J Ratain, et al.
The New England Journal of Medicine|April 20, 2001
Molecular predictors of survival after adjuvant chemotherapy for colon cancerT Watanabe, T T Wu, P J Catalano, et al.
Cancer|April 7, 1998
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literatureC Tellez, A B Benson, M T Lyster, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusB D Minsky, D Neuberg, D P Kelsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agentE Gupta, O I Olopade, M J Ratain, et al.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation|March 4, 2006
A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinomaP M Parikh, J Fuloria, G Babu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinomaA B Benson, E Mitchell, N Abramson, et al.
Cancer|November 7, 1998
High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology GroupS M Keller, L M Ryan, L R Coia, et al.
Pageof 8